These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15008257)

  • 1. Genetic and environmental aspect of polycystic ovary syndrome.
    Carmina E
    J Endocrinol Invest; 2003 Nov; 26(11):1151-9. PubMed ID: 15008257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.
    Mukherjee S; Shaikh N; Khavale S; Shinde G; Meherji P; Shah N; Maitra A
    Eur J Endocrinol; 2009 May; 160(5):855-62. PubMed ID: 19211708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review.
    Carvalho LML; Dos Reis FM; Candido AL; Nunes FFC; Ferreira CN; Gomes KB
    Endocr Regul; 2018 Oct; 52(4):208-221. PubMed ID: 31517612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
    Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
    Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
    Lin L; Du T; Huang J; Huang LL; Yang DZ
    Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.
    Martínez-García MA; San-Millán JL; Escobar-Morreale HF
    Gene; 2012 Apr; 497(1):38-44. PubMed ID: 22306327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.
    Escobar-Morreale HF; Luque-Ramírez M; San Millán JL
    Endocr Rev; 2005 Apr; 26(2):251-82. PubMed ID: 15561799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.
    Roldán B; San Millán JL; Escobar-Morreale HF
    Am J Pharmacogenomics; 2004; 4(2):93-107. PubMed ID: 15059032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic aspects between polycystic ovary syndrome and diabetes mellitus.
    Mendoza N
    Curr Diabetes Rev; 2011 Nov; 7(6):377-91. PubMed ID: 21864293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
    Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
    Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
    San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.
    Sozen I; Arici A
    Obstet Gynecol Surv; 2000 May; 55(5):321-8. PubMed ID: 10804539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
    Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
    Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome.
    Koika V; Marioli DJ; Saltamavros AD; Vervita V; Koufogiannis KD; Adonakis G; Decavalas G; Georgopoulos NA
    Eur J Endocrinol; 2009 Aug; 161(2):317-22. PubMed ID: 19465486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.